Workflow
人福医药(600079) - 2024 Q3 - 季度财报
HWHGHWHG(SH:600079)2024-10-29 09:27

Financial Performance - The company's operating revenue for Q3 2024 reached ¥6,282,091,319.93, representing a year-on-year increase of 9.66%[2] - The net profit attributable to shareholders for the same period was ¥478,599,417.99, reflecting a growth of 7.57% compared to the previous year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥432,119,904.58, with a slight increase of 0.04% year-on-year[2] - Total operating revenue for the first three quarters of 2024 reached ¥19,143,374,654.64, an increase of 5.68% compared to ¥18,111,717,932.04 in the same period of 2023[16] - Net profit for the first three quarters of 2024 was ¥2,107,380,778.33, a decrease of 7.69% from ¥2,283,150,716.38 in the previous year[18] - The net profit attributable to the parent company for Q3 2024 is CNY 1,589,694,392.14, a decrease of 10.1% compared to CNY 1,768,711,274.43 in Q3 2023[19] - The total comprehensive income for Q3 2024 is CNY 2,229,186,030.40, down from CNY 2,371,369,918.04 in Q3 2023, reflecting a decline of 6.0%[19] - The basic earnings per share for Q3 2024 is CNY 0.98, compared to CNY 1.09 in Q3 2023, indicating a decrease of 10.1%[19] - Net profit for the first three quarters of 2024 reached CNY 1.18 billion, compared to CNY 1.08 billion in the same period of 2023, marking an increase of 9.5%[25] - The total comprehensive income for Q3 2024 was CNY 1.34 billion, up from CNY 1.14 billion in Q3 2023, reflecting an increase of 18.2%[26] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥1,492,678,453.08, showing a significant increase of 53.35%[2][6] - Cash inflow from operating activities for the first three quarters of 2024 is CNY 18,308,686,331.63, an increase of 6.0% from CNY 17,265,475,023.60 in the same period of 2023[20] - The net cash flow from operating activities for the first three quarters of 2024 is CNY 1,492,678,453.08, up from CNY 973,378,234.08 in the same period of 2023, representing a growth of 53.3%[20] - The total cash and cash equivalents at the end of Q3 2024 is CNY 2,788,853,479.70, down from CNY 3,666,791,638.82 at the end of 2023[21] - The company reported a tax refund of CNY 75,388,365.61 in the first three quarters of 2024, compared to CNY 49,058,696.16 in the same period of 2023[20] - The company faced a net decrease in cash and cash equivalents of -65,984,661.35 RMB in the first three quarters of 2024, compared to -25,282,775.82 RMB in the same period of 2023[29] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥37,345,934,482.88, an increase of 3.15% from the end of the previous year[3] - The total assets of the company as of the end of the third quarter of 2024 were ¥37,345,934,482.88, an increase from ¥36,204,297,567.19 at the end of the third quarter of 2023[16] - The company's total liabilities increased to ¥16,325,922,163.45 from ¥16,105,685,461.71, marking a rise of 1.37%[16] - The total liabilities increased to CNY 6.42 billion in Q3 2024, up from CNY 6.06 billion in Q3 2023, reflecting a rise of 6.2%[23] - The company's equity increased to CNY 13.20 billion in Q3 2024, compared to CNY 12.75 billion in Q3 2023, an increase of 3.5%[23] Research and Development - Research and development expenses for the first three quarters were ¥1,093,259,846.85, compared to ¥1,001,169,520.67 in the same period last year, indicating a growth of 9.19%[18] - Research and development expenses decreased to CNY 5.31 million in 2024 from CNY 6.23 million in 2023, a reduction of approximately 11.7%[25] Stock and Financing Activities - The company approved the release of 574,500 restricted stocks for 147 incentive targets, which will be tradable starting July 16, 2024[10] - A total of 6,313,533 restricted stocks for 820 incentive targets were approved for release, effective September 2, 2024[10] - The company reported a financial expense of ¥327,271,864.94, which is significantly higher than the previous year's ¥211,681,340.37, indicating an increase of 54.67%[18] - The company raised 3,100,000,000.00 RMB through financing activities, an increase from 2,965,000,000.00 RMB in the previous year[29] - The total cash outflow for financing activities was 3,730,588,620.87 RMB, compared to 3,512,654,142.00 RMB in the previous year, indicating increased financial obligations[29]